{"id":"https://openalex.org/W2164151958","doi":null,"title":"Tuberous sclerosis-associated neoplasms express activated p42/44 mitogen-activated protein (MAP) kinase, and inhibition of MAP kinase signaling results in decreased in vivo tumor growth.","display_name":"Tuberous sclerosis-associated neoplasms express activated p42/44 mitogen-activated protein (MAP) kinase, and inhibition of MAP kinase signaling results in decreased in vivo tumor growth.","publication_year":2003,"publication_date":"2003-08-15","ids":{"openalex":"https://openalex.org/W2164151958","mag":"2164151958","pmid":"https://pubmed.ncbi.nlm.nih.gov/12960139"},"language":"en","primary_location":{"id":"pmid:12960139","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12960139","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111542076","display_name":"Baskaran Govindarajan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Baskaran Govindarajan","raw_affiliation_strings":["Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia 30322, USA","Emory University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia 30322, USA","institution_ids":["https://openalex.org/I150468666"]},{"raw_affiliation_string":"Emory University","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108629291","display_name":"Melissa C. Mizesko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa C Mizesko","raw_affiliation_strings":["Wake Forest Univ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wake Forest Univ","institution_ids":["https://openalex.org/I47251452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032241792","display_name":"Mark Steven Miller","orcid":"https://orcid.org/0000-0003-1191-0977","observed_orcids":["https://orcid.org/0000-0003-1191-0977"]},"institutions":[{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Steven Miller","raw_affiliation_strings":["Wake Forest Univ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wake Forest Univ","institution_ids":["https://openalex.org/I47251452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058275961","display_name":"Hiroaki Onda","orcid":"https://orcid.org/0000-0001-7973-5445","observed_orcids":["https://orcid.org/0000-0001-7973-5445"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hiroaki Onda","raw_affiliation_strings":["Harvard University ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard University ,","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Matthew Nunnelley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Nunnelley","raw_affiliation_strings":["Emory University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113529648","display_name":"Katherine A. Casper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine Casper","raw_affiliation_strings":["Emory University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078484855","display_name":"Daniel Jay Brat","orcid":"https://orcid.org/0000-0002-0633-6563","observed_orcids":["https://orcid.org/0000-0002-0633-6563"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Brat","raw_affiliation_strings":["Emory University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Cynthia Cohen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cynthia Cohen","raw_affiliation_strings":["Emory University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004887935","display_name":"Jack L. Arbiser","orcid":"https://orcid.org/0000-0002-6798-6383","observed_orcids":["https://orcid.org/0000-0002-6798-6383"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jack L Arbiser","raw_affiliation_strings":["Emory University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"last","author":{"id":null,"display_name":"Matthew Nunnelly","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew Nunnelly","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.9144,"has_fulltext":false,"cited_by_count":34,"citation_normalized_percentile":{"value":0.84941847,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"9","issue":"9","first_page":"3469","last_page":"75"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12049","display_name":"Tuberous Sclerosis Complex Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12049","display_name":"Tuberous Sclerosis Complex Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tuberous-sclerosis-complex","display_name":"tuberous sclerosis complex","score":0.9789999723434448},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.8339999914169312},{"id":"https://openalex.org/keywords/tuberin","display_name":"tuberin","score":0.8080000281333923},{"id":"https://openalex.org/keywords/hamartin","display_name":"hamartin","score":0.9599999785423279},{"id":"https://openalex.org/keywords/tsc2","display_name":"TSC2","score":0.8119999766349792},{"id":"https://openalex.org/keywords/tumor-suppressor-genes","display_name":"tumor suppressor","score":0.6869999766349792},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.8880000114440918},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.8999999761581421},{"id":"https://openalex.org/keywords/tumor-growth","display_name":"tumor growth","score":0.7879999876022339},{"id":"https://openalex.org/keywords/pharmacological-inhibition","display_name":"pharmacological inhibition","score":0.5059999823570251}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6080141663551331},{"id":"https://openalex.org/C132149769","wikidata":"https://www.wikidata.org/wiki/Q899651","display_name":"Mitogen-activated protein kinase","level":3,"score":0.6034814119338989},{"id":"https://openalex.org/C163035849","wikidata":"https://www.wikidata.org/wiki/Q15326910","display_name":"MAPK14","level":5,"score":0.5900783538818359},{"id":"https://openalex.org/C137361374","wikidata":"https://www.wikidata.org/wiki/Q6714442","display_name":"MAP kinase kinase kinase","level":4,"score":0.5498853921890259},{"id":"https://openalex.org/C90934575","wikidata":"https://www.wikidata.org/wiki/Q6593810","display_name":"Mitogen-activated protein kinase kinase","level":4,"score":0.5367988348007202},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5310293436050415},{"id":"https://openalex.org/C91734924","wikidata":"https://www.wikidata.org/wiki/Q18033952","display_name":"MAPKAPK2","level":5,"score":0.5124183297157288},{"id":"https://openalex.org/C138227536","wikidata":"https://www.wikidata.org/wiki/Q18030789","display_name":"MAPK7","level":5,"score":0.5096714496612549},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.49443912506103516},{"id":"https://openalex.org/C124160383","wikidata":"https://www.wikidata.org/wiki/Q14914383","display_name":"ASK1","level":5,"score":0.46167421340942383},{"id":"https://openalex.org/C159479382","wikidata":"https://www.wikidata.org/wiki/Q18030801","display_name":"MAP2K7","level":5,"score":0.44737565517425537},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.35978472232818604},{"id":"https://openalex.org/C82495950","wikidata":"https://www.wikidata.org/wiki/Q14911732","display_name":"Cyclin-dependent kinase 2","level":4,"score":0.31680673360824585},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.26666581630706787}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004247","descriptor_name":"DNA","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005091","descriptor_name":"Exons","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005799","descriptor_name":"Genes, Dominant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006579","descriptor_name":"Heterozygote","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012509","descriptor_name":"Sarcoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014402","descriptor_name":"Tuberous Sclerosis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D014402","descriptor_name":"Tuberous Sclerosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017353","descriptor_name":"Gene Deletion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019950","descriptor_name":"Mitogen-Activated Protein Kinase 1","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D020133","descriptor_name":"Reverse Transcriptase Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020928","descriptor_name":"Mitogen-Activated Protein Kinases","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D020935","descriptor_name":"MAP Kinase Signaling System","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D042501","descriptor_name":"Angiogenic Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048052","descriptor_name":"Mitogen-Activated Protein Kinase 3","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:12960139","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12960139","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"mag:2164151958","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12960139","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.979200005531311}],"study_designs":[],"awards":[{"id":"https://openalex.org/G115236584","display_name":"Cutaneous Hemangiomas and Signal Transduction","funder_award_id":"R01AR047901","funder_id":"https://openalex.org/F4320337362","funder_display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"},{"id":"https://openalex.org/G294002745","display_name":"SKIN DISEASES RESEARCH CORE CENTER","funder_award_id":"P30AR042687","funder_id":"https://openalex.org/F4320337362","funder_display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"},{"id":"https://openalex.org/G572449272","display_name":"ONCOGENES AND TRANSPLACENTAL CARCINOGENESIS","funder_award_id":"5r01es006501-04","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G6943580745","display_name":"TRANSPLACENTAL CARCINOGENESIS OF HETEROCYCLIC AMINES","funder_award_id":"5r01es008252-02","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000328302","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA012197","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337362","display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","ror":"https://ror.org/006zn3t30"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":55,"referenced_works":["https://openalex.org/W38036891","https://openalex.org/W93858677","https://openalex.org/W1802897102","https://openalex.org/W1918600217","https://openalex.org/W1930547966","https://openalex.org/W1964253791","https://openalex.org/W1968214041","https://openalex.org/W1970056068","https://openalex.org/W1971377850","https://openalex.org/W1980754624","https://openalex.org/W1989083115","https://openalex.org/W1989315352","https://openalex.org/W1989480480","https://openalex.org/W2009763836","https://openalex.org/W2012425194","https://openalex.org/W2018862580","https://openalex.org/W2021207380","https://openalex.org/W2029810183","https://openalex.org/W2031818280","https://openalex.org/W2032198484","https://openalex.org/W2040218616","https://openalex.org/W2047818921","https://openalex.org/W2051320260","https://openalex.org/W2052294041","https://openalex.org/W2068452613","https://openalex.org/W2076926699","https://openalex.org/W2078198865","https://openalex.org/W2088059131","https://openalex.org/W2088673647","https://openalex.org/W2088740611","https://openalex.org/W2094941511","https://openalex.org/W2103304405","https://openalex.org/W2109063774","https://openalex.org/W2113245366","https://openalex.org/W2119979409","https://openalex.org/W2121733985","https://openalex.org/W2126679757","https://openalex.org/W2129925175","https://openalex.org/W2132787700","https://openalex.org/W2133820317","https://openalex.org/W2137283707","https://openalex.org/W2141362788","https://openalex.org/W2143793112","https://openalex.org/W2143891754","https://openalex.org/W2146651717","https://openalex.org/W2147249316","https://openalex.org/W2151504205","https://openalex.org/W2159127121","https://openalex.org/W2164344519","https://openalex.org/W2169704588","https://openalex.org/W2170936754","https://openalex.org/W2171884143","https://openalex.org/W2235106477","https://openalex.org/W2417449567","https://openalex.org/W2917806833"],"related_works":["https://openalex.org/W2126429631","https://openalex.org/W1978240770","https://openalex.org/W2011063821","https://openalex.org/W2058598013","https://openalex.org/W2011872098","https://openalex.org/W3080368065","https://openalex.org/W2117664165","https://openalex.org/W2016682723","https://openalex.org/W2060015445","https://openalex.org/W1990797251"],"abstract_inverted_index":{"PURPOSE:":[0],"Tuberous":[1],"sclerosis":[2],"(TS)":[3],"is":[4,59,202],"a":[5,29,71,80,84,117,161,165,180,229],"common":[6],"autosomal":[7],"disorder":[8],"attributable":[9],"to":[10,186,216],"inactivation":[11],"of":[12,34,65,74,98,106,129,138,155,172,179,189,197,212,224,237],"the":[13,32,63,127,139,177,187,233],"tumor":[14,81,162,190,218],"suppressor":[15],"genes":[16],"tuberin":[17],"and":[18,48,95,125,136,194,209,235],"hamartin.":[19],"To":[20,54],"determine":[21,55],"whether":[22,56],"mitogen-activated":[23],"protein":[24],"(MAP)":[25],"kinase":[26,58,101,108,115,120,121,174,183,184,201,214,226],"signaling":[27,109,175],"plays":[28],"role":[30],"in":[31,67,83,93,102,122,133,164,192,204,207,220,232],"pathogenesis":[33],"TS,":[35,68],"we":[36,69],"stained":[37],"human":[38],"TS-associated":[39,75],"neoplasms":[40,151],"with":[41],"antibodies":[42],"directed":[43],"against":[44],"activated":[45,99,156,203],"MAP":[46,57,100,107,114,119,157,173,182,200,213,225],"kinase,":[47,158],"observed":[49],"high-level":[50,96,153],"expression.":[51],"EXPERIMENTAL":[52],"DESIGN:":[53],"functionally":[60],"important":[61],"for":[62,87,168],"development":[64],"neoplasia":[66,76,206],"established":[70],"murine":[72],"model":[73],"(Tsc2Ang1":[77],"cells)":[78],"from":[79],"arising":[82,163],"mouse":[85,166],"heterozygous":[86,167],"tuberin.":[88,169],"Tsc2Ang1":[89],"cells":[90,124],"demonstrate":[91,152],"tumorigenesis":[92],"vivo":[94,134,193],"expression":[97,154],"vitro.":[103],"The":[104,170],"functionality":[105],"was":[110],"assessed":[111],"by":[112,176],"inactivating":[113],"using":[116],"dominant-negative":[118,181],"tsc2ang1":[123],"assessing":[126],"effect":[128],"this":[130],"intervention":[131],"on":[132],"tumorigenicity":[135],"production":[137,196],"potent":[140],"angiogenic":[141],"factor":[142,146],"vascular":[143],"endothelial":[144],"growth":[145,191,219],"(VEGF).":[147],"RESULTS:":[148],"Human":[149],"TS-related":[150,205,238],"as":[159],"does":[160],"inhibition":[171,188,223],"introduction":[178],"leads":[185,215],"decreased":[195,217],"VEGF.":[198],"CONCLUSIONS:":[199],"mice":[208],"humans.":[210],"Inhibition":[211],"vivo.":[221],"Pharmacological":[222],"may":[227],"be":[228],"therapeutic":[230],"target":[231],"prevention":[234],"treatment":[236],"tumors.":[239]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}
